Home › Research › Brain tissue and pathology
Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease
Agostinho P, Cunha RA, Oliveira C.. Current pharmaceutical design, 2010-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Alzheimer's disease (AD) is the most common neurodegenerative disorder that affects the elderly. The increase of life-expectancy is transforming AD into a major health-care problem. AD is characterized by a progressive impairment of memory and other cognitive skills leading to dementia.
What this study adds
Evidence grade: Low
This is a narrative review. This review discusses how neuroinflammation and oxidative stress contribute to Alzheimer's disease pathogenesis. It highlights that amyloid-beta peptide oligomers accumulate extracellularly and are associated with reactive microglia and astrocytes as well as degeneration of neuronal processes.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Agostinho, P., Cunha, R. A., & Oliveira, C. (2010). Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Current pharmaceutical design. https://doi.org/10.2174/138161210793176572
Vancouver
Agostinho P, Cunha RA, Oliveira C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Current pharmaceutical design. 2010. doi:10.2174/138161210793176572. PMID: 20698820.
BibTeX
@article{agostinho2010-20698820,
author = {Agostinho, P. and Cunha, R. A. and Oliveira, C.},
title = {{Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease}},
journal = {Current pharmaceutical design},
year = {2010},
doi = {10.2174/138161210793176572},
pmid = {20698820},
url = {https://doi.org/10.2174/138161210793176572}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The increase of life-expectancy is transforming AD into a major health-care problem.
- AD is characterized by a progressive impairment of memory and other cognitive skills leading to dementia.
- The major pathogenic factor associated to AD seems to be amyloid-beta peptide (Aβ) oligomers that tend to accumulate extracellularly as amyloid deposits and are associated with reactive microglia and astrocytes as well as with degeneration of neuronal processes.
- The involvement of microglia and astrocytes in the onset and progress of neurodegenerative process in AD is becoming increasingly recognized, albeit it is commonly accepted that neuroinflammation and oxidative stress can have both detrimental and beneficial influences on the neural tissue.
Why it matters
This review discusses how neuroinflammation and oxidative stress contribute to Alzheimer's disease pathogenesis. It highlights that amyloid-beta peptide oligomers accumulate extracellularly and are associated with reactive microglia and astrocytes as well as degeneration of neuronal processes.
Study details
- Evidence strengthLow
How this study scored 45/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Current pharmaceutical design) |
| Journal's citation record | 2 / 4 | Current Pharmaceutical Design: journal h-index 208 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2010 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 678 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 37.7 citations a year over 18 year(s) since 2010 |
| Impact for its field and year | 4 / 6 | Cited 17.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 7 other studies in this library |
| Still being cited | 3 / 4 | Cited 118 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Catarina Resende Oliveira: h-index 97 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Coimbra: institution h-index 515 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 20698820) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Later studies that cite this one
7 studies in the alzhub library list this one in their references.
Related studies in Brain tissue and pathology from nearby years
Also in Brain tissue and pathology
124 studies in the library are filed under Brain tissue and pathology with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Brain tissue and pathology hub.